• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of NDI notification reviews completed during the month within 75 days of filing

Dictionary: Timely review of notifications of new dietary ingredients impacts the public health by preventing substances that are not actually dietary ingredients from being used in dietary supplements, and assuring that new dietary ingredients have adequate evidence for presumption of safety. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.

Information is current as of September 30, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeAnnual TargetPercentage
Oct 201390100
Nov 201390100
Dec 201390100
Jan 201490100
Feb 201490100
Mar 201490100
Apr 201490100
May 201490100
Jun 201490100
Jul 201490100
Aug 201490100
Sep 201490100

FY 2014 YTD: 100%

Number of NDI notification reviews due to be completed during the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2013N/A2
Nov 2013N/A1
Dec 2013N/A6
Jan 2014N/A1
Feb 2014N/A6
Mar 2014N/A2
Apr 2014N/A2
May 2014N/A8
Jun 2014N/A3
Jul 2014N/A3
Aug 2014N/A2
Sep 2014N/A3

FY 2014 YTD: 39

Number of NDI notification reviews completed during the month within 75 days of filing

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2013N/A2
Nov 2013N/A1
Dec 2013N/A6
Jan 2014N/A1
Feb 2014N/A6
Mar 2014N/A2
Apr 2014N/A2
May 2014N/A8
Jun 2014N/A3
Jul 2014N/A3
Aug 2014N/A2
Sep 2014N/A3

FY 2014 YTD: 39

Total number of NDI notification reviews completed during the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2013N/A2
Nov 2013N/A1
Dec 2013N/A6
Jan 2014N/A1
Feb 2014N/A6
Mar 2014N/A2
Apr 2014N/A2
May 2014N/A8
Jun 2014N/A3
Jul 2014N/A3
Aug 2014N/A2
Sep 2014N/A3

FY 2014 YTD: 39

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.